Minneapolis, MNNCT07834203Now EnrollingIRB Ready

Early Psychosis Clinical Trial in Minneapolis, MN

Access cutting-edge early psychosis treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.

Sponsored by University of Minnesota

Quick Self-Assessment

See if you qualify for this Minneapolis location

Preparing your pre-screening questions…

Expert Care in Minneapolis

Access early psychosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related early psychosis treatment provided free

Apply for This Minneapolis Location

Check if you qualify for this early psychosis clinical trial in Minneapolis, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minneapolis

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minneapolis site if eligible
  4. 4Begin participation

About This Early Psychosis Study in Minneapolis

This observational study will examine behavioral and electroencephalography measures related to state representation in individuals with early psychosis and healthy control participants. Participants will complete clinical interviews, self-report measures, cognitive assessments, computerized behavioral tasks, and EEG assessments. The study will evaluate performance and computed parameters from the Translational Orientation Pattern Expectancy task and Translational Bandit Task, along with EEG variables related to cognitive control, reward processing, and neural synchrony. The study aims to better understand heterogeneity in early psychosis and identify neurocognitive and neurophysiologic markers that may inform future precision psychiatry approaches.

Sponsor: University of Minnesota

Who Can Participate

Inclusion Criteria

All participants:
Aged between 15 and 45 years
English proficiency, as determined by staff observation and participant self-report
Estimated IQ at or above 70, as estimated by cognitive assessments
Estimated visual acuity at 20/40, as estimated by the visual acuity test Early Psychosis participants:
Clinical diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, psychosis NOS, bipolar disorder with psychosis, or major depressive disorder with psychosis
Age 35 years or younger, or age 36 to 45 years with onset of psychotic symptoms within the previous 5 years
Achieved clinical stability, defined as outpatient status for at least one month prior to study participation

Exclusion Criteria

All participants:
Unable or unwilling to provide informed consent
Unable to demonstrate adequate decisional capacity, in the judgment of the consenting study staff member
Previous clinically significant head injury or prolonged unconsciousness, as determined by the investigators
Meets criteria for severe substance or alcohol use disorder within 3 months of behavioral assessment
Presence of any major medical condition that, in the opinion of the investigators, would impede participation or put the participant at additional risk
Has participated in significant formal cognitive training programs, as determined by the investigators
Meets criteria for clinical risk of suicidal behavior Early Psychosis participants: \- Presence of a major neurological disorder Healthy Control participants:
Meets DSM-5 criteria for psychotic or bipolar disorder
Has a first-degree family history of psychotic or bipolar disorder
Presence of a major neurological disorder

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minneapolis?

Yes, this clinical trial (NCT07834203) has an active research site in Minneapolis, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Early Psychosis Treatment Options in Minneapolis, MN

If you're searching for early psychosis treatment options in Minneapolis, MN, this clinical trial (NCT07834203) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced early psychosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all early psychosis clinical trials near you to find additional studies recruiting in your area.

More Schizophrenia Trials in Minneapolis, MN

See all schizophrenia clinical trials recruiting in Minneapolis — not just this study.

Browse Schizophrenia Trials in Minneapolis →

Browse More Trials by Condition

Schizophrenia TrialsAll Conditions →

Ready to Join in Minneapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minneapolis, MN